Glenda S. Overbeck

Oncovance Technologies, Inc. provides information management and analytical services and solutions to the healthcare industry. It provides database and information management to pharmaceutical and medical device manufacturers to promote and differentiate therapeutics, IT tools that improve and personalize treatment decisions & support physician users, and platforms to drive diagnostics development and sales. The company was founded by Kevin M. Slawin, Peter T. Scardino, and Michael W. Kattan and is headquartered in Houston, TX.

Prokaryon Technologies, Inc., is a animal health company that develops solutions for the prevention and control of economically devastating diseases in food animals. The focus of the company is the discovery, development, and commercialization of innovative veterinary products. Prokaryon's lead product is a genomics-derived vaccine to prevent shipping fever in cattle

BCM Technologies Inc (BCM Technologies) is a venture capital subsidiary of Baylor University founded in 1983. The firm is headquartered in Houston, Texas.

Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX.

Progression Therapeutics, Inc. develops prognostic tests and therapies for the treatment of cancer. Its products are used in the treatment of primary and metastatic cancer. The firm develops a tumor suppressor gene product that has demonstrated potent anti-tumor activity both in vitro and in vivo. The company was founded on December 27, 2001 and is headquartered in Houston, TX.